Structure-affinity relationships of halogenated predicentrine and glaucine derivatives at D1 and D2 dopaminergic receptors:: halogenation and D1 receptor selectivity

被引:35
作者
Asencio, M
Hurtado-Guzmán, C
López, JJ
Cassels, BK [1 ]
Protais, P
Chagraoui, A
机构
[1] Univ Chile, Fac Sci, Dept Chem, Santiago, Chile
[2] Univ Chile, Fac Sci, Millennium Inst Adv Studies Cell Biol & Biotechno, CBB, Santiago, Chile
[3] Univ Chile, Fac Med, ICBM, Programme Mol & Clin Pharmacol, Santiago 70000 7, Casilla, Chile
[4] Univ Rouen, Fac Med & Pharm, Physiol Lab, F-7600 Rouen, France
关键词
aporphines; halogenated predicentrines; halogenated glaucines; dopamine receptor affinities;
D O I
10.1016/j.bmc.2005.03.022
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Halogenation of the aporphine alkaloid boldine at the 3-position leads to increased affinity for rat brain D-1-like dopaminergic receptors with some selectivity over D-2-like receptors. A series of 3-halogenated and 3,8-dihalogenated (halogen = Cl, Br or 1) derivatives of predicentrine (9-O-methylboldine) and glaucine (2,9-di-O-methylboldine) were prepared and assayed for binding at D-1 and D-2 sites. Halogenation of predicentrine led to strong increases in affinity for D-1-like receptors, while the affinities for D-2-like receptors were either practically unchanged or reduced three- to fourfold. Halogenated glaucine derivatives did not show any clear trend towards enhanced selectivity, and the affinities were poor and similar to or worse than the values previously recorded for glaucine itself. Together with earlier work on boldine derivatives, these results suggest that the 2-hydroxy group on the aporphine skeleton may determine a binding mode favoring D-1-like over D-2-like receptors, with enhanced affinity when the C-3 position is halogenated. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3699 / 3704
页数:6
相关论文
共 39 条
[1]   Administration of the D1-like dopamine receptor antagonist SCH-23390 into the medial nucleus accumbens shell attenuates cocaine priming-induced reinstatement of drug-seeking behavior in rats [J].
Anderson, SM ;
Bari, AA ;
Pierce, RC .
PSYCHOPHARMACOLOGY, 2003, 168 (1-2) :132-138
[2]  
ASENCIO M, 1993, BOL SOC CHIL QUIM, V38, P331
[3]   Biochemical and behavioral effects of boldine and glaucine on dopamine systems [J].
Asencio, M ;
Delaquerrière, B ;
Cassels, BK ;
Speisky, H ;
Comoy, E ;
Protais, P .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1999, 62 (01) :7-13
[4]   CHARACTERIZATION OF THE BINDING OF H-3-SCH 23390, A SELECTIVE D-1 RECEPTOR ANTAGONIST LIGAND, IN RAT STRIATUM [J].
BILLARD, W ;
RUPERTO, V ;
CROSBY, G ;
IORIO, LC ;
BARNETT, A .
LIFE SCIENCES, 1984, 35 (18) :1885-1893
[5]   CLONING AND EXPRESSION OF A RAT D2 DOPAMINE RECEPTOR CDNA [J].
BUNZOW, JR ;
VANTOL, HHM ;
GRANDY, DK ;
ALBERT, P ;
SALON, J ;
CHRISTIE, MJ ;
MACHIDA, CA ;
NEVE, KA ;
CIVELLI, O .
NATURE, 1988, 336 (6201) :783-787
[6]  
CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
[7]  
COX RF, 1988, J PHARMACOL EXP THER, V247, P355
[8]   MOLECULAR-CLONING AND EXPRESSION OF THE GENE FOR A HUMAN D1 DOPAMINE RECEPTOR [J].
DEARRY, A ;
GINGRICH, JA ;
FALARDEAU, P ;
FREMEAU, RT ;
BATES, MD ;
CARON, MG .
NATURE, 1990, 347 (6288) :72-76
[9]   Synthesis and dopaminergic properties of benzo-fused analogues of quinpirole and quinelorane [J].
Doll, MKH ;
Nichols, DE ;
Kilts, JD ;
Prioleau, C ;
Lawler, CP ;
Lewis, MM ;
Mailman, RB .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (05) :935-940
[10]   D1 dopamine receptor regulates alcohol-motivated behaviors in the bed nucleus of the stria terminalis in alcohol-preferring (P) rats [J].
Eiler, WJA ;
Seyoum, R ;
Foster, KL ;
Mailey, C ;
June, HL .
SYNAPSE, 2003, 48 (01) :45-56